HBV REPLICATION DURING TENOFOVIR THERAPY IS FREQUENT IN HIV/HBV-COINFECTION.

BORIS DOI
Publisher DOI
PubMed ID
36242550
Description
In the Swiss HIV Cohort Study, 61/222 (27%) HIV-suppressed persons with chronic hepatitis B virus (HBV) infection had HBV replication after two years on tenofovir, of whom 77% were suppressed thereafter. Self-reported adherence to therapy and HBV viral load at tenofovir initiation were predictors of persistent replication.
Date of Publication
2023-02-18
Publication Type
Article
Subject(s)
300 - Social sciences, sociology & anthropology::360 - Social problems & social services
600 - Technology::610 - Medicine & health
500 - Science::570 - Life sciences; biology
Keyword(s)
Coinfection hepatitis B virus human immunodeficiency virus tenofovir viral replication
Language(s)
en
Contributor(s)
Boillat-Blanco, Noémie
Günthard, Huldrych F
Stöckle, Marcel
Bernasconi, Enos
Schmid, Patrick
Calmy, Alexandra
Additional Credits
Universitätsklinik für Infektiologie
Institut für Infektionskrankheiten (IFIK)
Series
Clinical infectious diseases
Publisher
Oxford University Press
ISSN
1537-6591
Access(Rights)
open.access
Show full item